← back to healthcare-executive-change-signal
Financial analysis · adoption-ready estimate
Healthcare Executive Change Signal | C-Suite Movement Alerts for Health Tech Vendors
If an entrepreneur "adopted" this product today, here's the realistic math.
Fermi summary
Land 35 health tech vendors at $10k/year and you hit $350k ARR - but Definitive Healthcare already owns this shelf space, so you're really betting on being faster and cheaper, which puts honest odds around 11%.
Market size (TAM)
$12.0M
~1,000 US health tech vendors actively selling into hospitals and payers × $12k avg annual team license for executive change intelligence = $12M niche TAM
Year-1 ARR range
$150k - $850k
midpoint $350k
Investment to production
$42k
Dev: $22k for data pipeline (press release scraping, LinkedIn job-change monitoring, SEC 8-K parsing) + alert engine + Salesforce/HubSpot in
Probability of success
11%
P(reaching mid case in 12 months)
Expected take-home Y1
$-25000
probability-weighted, after investment
Go-to-market motion
Cold outbound to VP Sales and CROs at 1,500 health tech vendors via HIMSS member lists and LinkedIn → 20 demos/month → annual team licenses at $8-15k targeting healthcare sales teams of 5-25 reps.
Key risks
- LinkedIn aggressively blocks scraping and is the primary source for detecting executive job changes - a terms-of-service enforcement or IP ban kills the core data pipeline overnight with no clean fallback
- Definitive Healthcare already sells executive change alerts as part of their $50k+/year platform with a 300-person sales force, making it nearly impossible to win on data completeness while also undercutting on price
- Health tech vendor sales cycles run 6-9 months and procurement requires security reviews, meaning you burn through $40k investment before the first renewal class arrives and proves retention
Generated by the Wishdeal Factory financial-analysis agent. Numbers are honest Fermi estimates, not guarantees. Real outcomes depend on the operator. The studio is bullish on the engineering quality, agnostic on the business outcome.